The site uses anonymous third party analytic cookies: in accessing any element/area of the site outside of this banner, you consent to receiving cookies.

NHS transformation, GIRFT and procurement: what do they mean for MedTech?

  Wilmington Healthcare’s free webinar explores how the latest NHS developments are affecting the MedTech industry A free webinar,...

Value for money: what does it mean in the new NHS procurement landscape?

Oli Hudson, of the Wilmington Healthcare Consulting Team, assesses the immediate and longer-term priorities of the NHS procurement category...

New local NHS models help to deliver integrated care

GP practices have been joining forces to create integrated units that can each serve a patient population of around 30,000-50,000 – about the same...

MedTech industry must meet demands of key NHS efficiency drive

Sue Thomas and Steve How, of Wilmington Healthcare, explain why the Getting It Right First Time (GIRFT) programme is critical for...

Network Events Rebrand

Formerly known as the Wilmington Healthcare Network Events, the series of regional collaborative meetings have now rebranded to fall under Health...

Long-term planning could transform NHS spending

Steve How and Paul Midgley, of the Wilmington Healthcare Consulting Team, explore what the NHS 10-year plan could mean for medicines...

How can medtech engage with key stakeholders in new NHS care models?

Oli Hudson, of the Wilmington Healthcare consulting team, explores the value of a blended learning approach, underpinned by data, insight and...

NHS medtech costs will face increased scrutiny

Oli Hudson, of the Wilmington Healthcare consulting team, explains how NHS procurement transformation will impact on the medtech industry...

How can pharma engage with key stakeholders on NHS service transformation?

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for...

How can pharma support NHS service change?

Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, find some answers in NHS England guidance for...

How can pharma engage with key decision-makers in new, collaborative NHS care models?

Paul Midgley, Sue Thomas, Steve How and Oli Hudson, of Wilmington Healthcare, explore how pharma should adapt its approach Since the publication of...

Managing local population needs is key for the NHS

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore population-based planning in the NHS and what this means for...

New NHS care models require innovative, partnership approach from pharma

Steve How, Paul Midgley and Sue Thomas, of Wilmington Healthcare, explore how pharma should respond to the NHS’s move towards more collaborative,...

2017: A year of Transition and Transformation for the NHS

Paul Midgley and Steve How, of Wilmington Healthcare, look back at some of the key developments in the NHS in the past year To plug an anticipated...